Anebulo Pharmaceuticals
ANEB
ANEB
18 hedge funds and large institutions have $29.4M invested in Anebulo Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
21% less capital invested
Capital invested by funds: $37.3M → $29.4M (-$7.91M)
32% less ownership
Funds ownership: 87.04% → 55.05% (-32%)
Holders
18
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$207K | |
| 2 | +$148K | |
| 3 | +$65.7K | |
| 4 |
Goldman Sachs
New York
|
+$62.3K |
| 5 |
HF
HRT Financial
New York
|
+$30K |
Top Sellers
| 1 | -$368K | |
| 2 | -$100K | |
| 3 | -$27K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$24 |
| 5 |
JP Morgan Chase
New York
|
-$1 |